SCHEMBL20966312

SCHEMBL20966312

CCn1c2ccccc2c2cc(Nc3ncccc3C(=O)NCCN3CCN(C(=O)OC(C)(C)C)CC3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 1/20 0.48
▸ TGFBR2 P37173 1/20 0.48
▸ ACKR3 P25106 2/20 0.46
▸ CNR2 P34972 1/20 0.45
▸ PTGER4 P35408 2/20 0.44
▸ NPY5R Q15761 2/20 0.43
▸ LMNA P02545 3/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ UTS2R Q9UKP6 1/20 0.41
▸ PTGES O14684 1/20 0.41
▸ RAC1 P63000 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20945434 0.81 RAC1 (0.60) PTGER4NPY5RLMNARAC1MAPT
SCHEMBL20945441 0.78 MAPT (0.47) NPY5RLMNAPTGESMAPTKDM4E
SCHEMBL20945458 0.76 HSD17B10 (0.51) LMNATHRBMAPTKDM4E
SCHEMBL20945460 0.75 MAPT (0.61) NPY5RLMNAPTGESMAPTKDM4E
SCHEMBL20945442 0.74 POLB (0.66) TGFBR1TGFBR2ACKR3LMNAUTS2R
SCHEMBL20945443 0.74 POLB (0.66) TGFBR1TGFBR2ACKR3LMNAUTS2R
SCHEMBL20945446 0.72 MAPT (0.66) LMNAPTGESTP53MAPTKDM4E
SCHEMBL31758308 0.71 ACKR3 (0.59) TGFBR1TGFBR2ACKR3LMNACHRM2
SCHEMBL20966382 0.70 NPY5R (0.63) NPY5RLMNAPTGESRAC1MAPT
SCHEMBL8148560 0.70 ZAP70 (0.48) CNR2RAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2020-08-04 — — US disclosed
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIVERSITY OF PUERTO RICO (PR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB TGFBR1 3928/4885TGFBR2 3748/4885ACKR3 82/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS TGFBR1 4053/4885TGFBR2 3870/4885ACKR3 85/4885
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, HRAS TGFBR1 4179/4885TGFBR2 3936/4885ACKR3 86/4885
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents CDC42, ARHGEF2, GDI2 TGFBR1 3842/4885TGFBR2 3693/4885ACKR3 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback